more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men

October 2013

You'll hear more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men.

Drug companies spend millions each year promoting these products.

But there's not much evidence of significant improvements with testosterone replacement...and even less evidence of long-term safety.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Liver Disease myths about using meds in chronic liver disease
Women's Health Yaz Plus, which is just a new version of Yaz (drospirenone/ethinyl estradiol) with FOLATE
Women's Health new option for treating uterine fibroids called Fibristal (fye-BRISS-tal, ulipristal)
Dermatology Recent warnings about acetaminophen will raise more questions about serious drug-induced skin reactions
Cardiology Many patients don't get appropriate med DOSES after a heart attack
Interactions P-glycoprotein drug interactions
Malaria Stronger warnings about mefloquine will mean more questions about what meds to use to prevent malaria
Veterinary Medicine More pharmacies are providing meds for pets
Allergic Reactions More patients who are allergic to penicillin will get a cephalosporin for common respiratory tract infections
Osteoporosis how to manage osteoporosis when patients don't get enough benefit from a bisphosphonate
Men's Health more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men